To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
194.97-0.1% from last year
Operating profits
35.76+52.82% from last year
Net income
21.00+99.81% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Net worth487.55460.34440.45400.28323.37332.52361.91388.67437.62
Fixed assets218.53215.96240.94261.68289.37364.45389.20406.18452.48
Debt41.3342.2942.8551.32220.45297.99306.89311.62335.21
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating37.2936.6341.10131.8477.6045.3331.1958.9346.88
Investing -7.21-50.83-16.7356.49-4.75-11.33-11.48-18.322.92
Financing -1.08-0.57-9.48-162.24-73.00-35.17-39.23-44.13-46.35

Financial ratios

Profitability ratiosinfo2
ROA4.64%
ROE6.01%
ROCE8.67%
EPS21.31%
Net profit margin4.74%
Operating profit margin11.83%
Dividend per share
Operational ratiosinfo2
Quick ratio2.99%
Current ratio4.53%
Interest coverage477.45%
Assets turnover0.98%
Debt to equity0.08%
Valuation ratiosinfo2
P/E ratio16.26%
P/B ratio1.31%
Dividend yield
EV/EBITDA
Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.
personal

Grow your wealth with more research recommendations

+91